These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11589774)

  • 1. Fatal liver infarction after transjugular intrahepatic portosystemic shunt procedure.
    Mayan H; Kantor R; Rimon U; Golubev N; Heyman Z; Goshen E; Shalmon B; Weiss P
    Liver; 2001 Oct; 21(5):361-4. PubMed ID: 11589774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segmental liver ischemia/infarction after elective transjugular intrahepatic portosystemic shunt creation: clinical outcomes in 10 patients.
    Lopera JE; Katabathina V; Bosworth B; Garg D; Kroma G; Garza-Berlanga A; Suri R; Wholey M
    J Vasc Interv Radiol; 2015 Jun; 26(6):835-41. PubMed ID: 25661437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic infarction: unusual complication of a transjugular intrahepatic portosystemic shunt.
    Sawhney R; Wall SD; Yee J; Hayward I
    J Vasc Interv Radiol; 1997; 8(1 Pt 1):129-32. PubMed ID: 9025052
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver infarction after transjugular intrahepatic portosystemic shunt in a liver transplant recipient.
    Wang MY; Potosky DR; Khurana S
    Hepatology; 2011 Nov; 54(5):1887-8. PubMed ID: 21932409
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of Clinical Outcomes, Clinical Manifestations, and Risk Factors for Hepatic Infarction After Transjugular Intrahepatic Portosystemic Shunt Placement (TIPS): A Retrospective Comparative Study.
    Tuifua TS; Partovi S; Remer EM; Ragheb J; Bullen JA; Kattan MW; Kapoor B
    Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1512-1523. PubMed ID: 35851823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].
    Grønbaek H; Astrup LB; Nielsen DT; Vilstrup H
    Ugeskr Laeger; 2003 Jan; 165(5):439-42. PubMed ID: 12599838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites.
    Andrade RJ; Martin-Palanca A; Fraile JM; Alcantara R; Carmona C; Medina MC; Muñoz V; Melgarejo F
    J Clin Gastroenterol; 1996 Jun; 22(4):305-7. PubMed ID: 8771428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spontaneous bacteremia due to Salmonella hadar in liver cirrhosis with transjugular intrahepatic portosystemic shunt].
    Barrio J; Castiella A; Von Wichman MA; Cosme A; López P; Arenas JI
    Gastroenterol Hepatol; 1999 Feb; 22(2):79-81. PubMed ID: 10193091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment.
    Alessandria C; Gaia S; Marzano A; Venon WD; Fadda M; Rizzetto M
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):607-12. PubMed ID: 15167164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites.
    Martinet JP; Legault L; Cernacek P; Roy L; Dufresne MP; Spahr L; Fenyves D; Pomier-Layrargues G
    J Hepatol; 1996 Nov; 25(5):700-6. PubMed ID: 8938548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain regional homogeneity changes following transjugular intrahepatic portosystemic shunt in cirrhotic patients support cerebral adaptability theory--a resting-state functional MRI study.
    Ni L; Qi R; Zhang LJ; Zhong J; Zheng G; Wu X; Fan X; Lu GM
    Eur J Radiol; 2014 Mar; 83(3):578-83. PubMed ID: 24299611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early TIPS failure in association with left mesenterico-gonadal spontaneous portosystemic venous shunt; a case report.
    Raissi D; Roney EA; Issa MM; Sanampudi S; Winkler MA
    Clin Imaging; 2019; 53():200-203. PubMed ID: 30419415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.
    Krieger S; Jauss M; Jansen O; Stiehl A; Sauer P; Geissler M; Theilmann L; Krieger D
    J Hepatol; 1997 Jul; 27(1):121-6. PubMed ID: 9252084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.
    Fonio P; Discalzi A; Calandri M; Doriguzzi Breatta A; Bergamasco L; Martini S; Ottobrelli A; Righi D; Gandini G
    Radiol Med; 2017 Sep; 122(9):713-721. PubMed ID: 28510807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular liver biopsy after transjugular intrahepatic portosystemic shunt (TIPS) or direct intrahepatic portocaval shunt (DIPS): Is it feasible, effective, and safe?
    Kaufman C; Aryafar H; Minocha J; Kinney T
    Diagn Interv Imaging; 2018 May; 99(5):331-335. PubMed ID: 29366793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
    J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.